4//SEC Filing
Sistilli Carlo 4
Accession 0001171843-25-000869
CIK 0001540159other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:02 PM ET
Size
11.4 KB
Accession
0001171843-25-000869
Insider Transaction Report
Form 4
Sistilli Carlo
Director
Transactions
- Award
Common Shares
2025-02-12$1.92/sh+10,416$19,999→ 10,416 total
Holdings
- 522(indirect: Held by York-Cav Enterprises, Inc.)
Common Shares
Footnotes (3)
- [F1]On February 12, 2025, the Reporting Person purchased in a private placement, 10,416 common shares, without par value, of the Issuer, for a purchase price of $1.92 per share.
- [F2]Shares reported reflect a 1-for-7 reverse share split effective October 11, 2023.
- [F3]York-Cav Enterprises, Inc. is partially owned by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Edesa Biotech, Inc.
CIK 0001540159
Entity typeother
Related Parties
1- filerCIK 0001777988
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:02 PM ET
- Size
- 11.4 KB